From the Section on Neuroimaging in Mood and Anxiety Disorders, NIMH, Bethesda, Md.; the Department of Psychiatry and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, U.K.; Addenbrooke's Hospital, Cambridge; Center for Cognitive Neuroimaging, Donders Institute for Brain, Cognition, and Behavior, Department of Psychiatry, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; and the Laureate Institute for Brain Research and Department of Psychiatry, Oklahoma University College of Medicine, Tulsa.